Next Article in Journal
Extraordinary Nanocrystalline Pb Whisker Growth from Bi-Mg-Pb Pools in Aluminum Alloy 6026 Moderated through Oriented Attachment
Previous Article in Journal
Characterization and Laser Structuring of Aqueous Processed Li(Ni0.6Mn0.2Co0.2)O2 Thick-Film Cathodes for Lithium-Ion Batteries
Previous Article in Special Issue
Cubic Nanoparticles for Magnetic Hyperthermia: Process Optimization and Potential Industrial Implementation
Review

Nanotechnology Integration for SARS-CoV-2 Diagnosis and Treatment: An Approach to Preventing Pandemic

1
Department of Pharmacy Practice, College of Pharmacy, AlMaarefa University, Dariyah, Riyadh 13713, Saudi Arabia
2
Department of Pharmacy, Tripura University (A Central University), Suryamaninagar 799022, Tripura (W), India
3
Department of Pharmaceutical Science, Faculty of Pharmacy, Universitas Airlangga, Surabaya 60115, Indonesia
4
Department of Pharmaceutical Science, Assam University (A Central University), Silchar 788011, Assam, India
5
Department of Pharmaceutical Sciences, Faculty of Science and Engineering, Dibrugarh University, Dibrugarh 786004, Assam, India
6
School of Pharmacy, Management and Science University, Seksyen 13, Shah Alam 40100, Selangor, Malaysia
7
Department of Pharmaceutics, Government College of Pharmacy, Bangalore 560027, Karnataka, India
8
Basic Sciences Department, College of Applied Medical Sciences, King Saud bin Abdulaziz University for Health Sciences, Alahsa 31982, Saudi Arabia
9
King Abdullah International Medical Research Center, Alahsa 31982, Saudi Arabia
10
Department of Clinical Pharmacy, Faculty of Pharmacy, Northern Border University, Rafha 91911, Saudi Arabia
11
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Northern Border University, Rafha 91911, Saudi Arabia
12
Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Hofuf, Al-Ahsa 31982, Saudi Arabia
13
Department of Pharmaceutics, Vidya Siri College of Pharmacy, Off Sarjapura Road, Bangalore 560035, India
14
Department of Biotechnology and Food Technology, Durban University of Technology, Durban 4001, South Africa
*
Authors to whom correspondence should be addressed.
Academic Editor: Angelo Ferraro
Nanomaterials 2021, 11(7), 1841; https://doi.org/10.3390/nano11071841
Received: 22 June 2021 / Revised: 11 July 2021 / Accepted: 14 July 2021 / Published: 16 July 2021
(This article belongs to the Special Issue Nanomaterials for Biomedical and Biotechnological Applications)
The SARS-CoV-2 outbreak is the COVID-19 disease, which has caused massive health devastation, prompting the World Health Organization to declare a worldwide health emergency. The corona virus infected millions of people worldwide, and many died as a result of a lack of particular medications. The current emergency necessitates extensive therapy in order to stop the spread of the coronavirus. There are various vaccinations available, but no validated COVID-19 treatments. Since its outbreak, many therapeutics have been tested, including the use of repurposed medications, nucleoside inhibitors, protease inhibitors, broad spectrum antivirals, convalescence plasma therapies, immune-modulators, and monoclonal antibodies. However, these approaches have not yielded any outcomes and are mostly used to alleviate symptoms associated with potentially fatal adverse drug reactions. Nanoparticles, on the other hand, may prove to be an effective treatment for COVID-19. They can be designed to boost the efficacy of currently available antiviral medications or to trigger a rapid immune response against COVID-19. In the last decade, there has been significant progress in nanotechnology. This review focuses on the virus’s basic structure, pathogenesis, and current treatment options for COVID-19. This study addresses nanotechnology and its applications in diagnosis, prevention, treatment, and targeted vaccine delivery, laying the groundwork for a successful pandemic fight. View Full-Text
Keywords: COVID-19; nanotechnology; vaccines; sanitizers; biosensors COVID-19; nanotechnology; vaccines; sanitizers; biosensors
Show Figures

Figure 1

MDPI and ACS Style

Asdaq, S.M.B.; Ikbal, A.M.A.; Sahu, R.K.; Bhattacharjee, B.; Paul, T.; Deka, B.; Fattepur, S.; Widyowati, R.; Vijaya, J.; Al mohaini, M.; Alsalman, A.J.; Imran, M.; Nagaraja, S.; Nair, A.B.; Attimarad, M.; Venugopala, K.N. Nanotechnology Integration for SARS-CoV-2 Diagnosis and Treatment: An Approach to Preventing Pandemic. Nanomaterials 2021, 11, 1841. https://doi.org/10.3390/nano11071841

AMA Style

Asdaq SMB, Ikbal AMA, Sahu RK, Bhattacharjee B, Paul T, Deka B, Fattepur S, Widyowati R, Vijaya J, Al mohaini M, Alsalman AJ, Imran M, Nagaraja S, Nair AB, Attimarad M, Venugopala KN. Nanotechnology Integration for SARS-CoV-2 Diagnosis and Treatment: An Approach to Preventing Pandemic. Nanomaterials. 2021; 11(7):1841. https://doi.org/10.3390/nano11071841

Chicago/Turabian Style

Asdaq, Syed M.B., Abu M.A. Ikbal, Ram K. Sahu, Bedanta Bhattacharjee, Tirna Paul, Bhargab Deka, Santosh Fattepur, Retno Widyowati, Joshi Vijaya, Mohammed Al mohaini, Abdulkhaliq J. Alsalman, Mohd. Imran, Sreeharsha Nagaraja, Anroop B. Nair, Mahesh Attimarad, and Katharigatta N. Venugopala 2021. "Nanotechnology Integration for SARS-CoV-2 Diagnosis and Treatment: An Approach to Preventing Pandemic" Nanomaterials 11, no. 7: 1841. https://doi.org/10.3390/nano11071841

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop